Cadrenal Therapeutics (CVKD) Earnings Date & Reports

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CVKD is expected to report earnings to fall 37.93% to -125 cents per share on August 07

Cadrenal Therapeutics CVKD Stock Earnings Reports

Q2'25

Est.

$-1.26

Q4'24

Missed

by $1.88

Q3'24

Missed

by $2.06

Q2'24

Missed

by $2.13

Q1'24

Missed

by $0.03

The last earnings report on March 13 showed earnings per share of -202 cents, missing the estimate of -15 cents. With 46.28K shares outstanding, the current market capitalization sits at 25.96M.

View a ticker or compare two or three

Compare

CVKD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CVKD
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

822 A1A North

Phone

+1 904 300-0701

Employees

Web

https://www.cadrenal.com